Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes

Fig. 1

Univariate correlations between plasma ceramide concentrations and hepatic markers of NAFLD in GEPSAD and LIRA-NAFLD (shown as a heatmap). Only correlations remaining statistically significant after Bonferroni correction were reported in the heatmap (i.e. when p < 0.0063). Liver fat content corresponds to the value determined by MRI-PDFF. FibroTest® and NashTest® were not performed in LIRA-NAFLD (grey cells). Abbreviations: FIB-4, fibrosis-4 index; FNI, fibrotic NASH index; LCFA, long-chain fatty acid; NFS, NAFLD fibrosis score; VLSFA, very long-chain saturated fatty acid

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840